Impact of oncogenic pathways on evasion of antitumour immune responsesStefani Spranger, Thomas F. Gajewski|Nature reviews. Cancer|2018Cited by 652
Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironmentStefani Spranger, Thomas F. Gajewski|Journal for ImmunoTherapy of Cancer|2014Cited by 543
Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancerMaria Zagorulya, Stefani Spranger|Immunity|2023Cited by 145
Lack of CD8 <sup>+</sup> T cell effector differentiation during priming mediates checkpoint blockade resistance in non–small cell lung cancerBrendan Horton, Stefani Spranger|Science Immunology|2021Cited by 127
Deciphering the immunopeptidome in vivo reveals new tumour antigensAlex M. Jaeger, Tyler Jacks, Lauren Stopfer et al.|Nature|2022Cited by 104